The effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention-deficit/hyperactivity disorder

Abstract Background This study aimed to evaluate the effects of guanfacine on the anterior and posterior segments of the eye. Methods This prospective study included 32 children and adolescents with Attention-deficit/hyperactivity disorder (ADHD). The participants underwent a detailed ophthalmologic...

Full description

Saved in:
Bibliographic Details
Main Authors: Işıl Merve Torun, Zeynep Vatansever Pinar, Şeyma İlhan
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-025-03886-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571957638332416
author Işıl Merve Torun
Zeynep Vatansever Pinar
Şeyma İlhan
author_facet Işıl Merve Torun
Zeynep Vatansever Pinar
Şeyma İlhan
author_sort Işıl Merve Torun
collection DOAJ
description Abstract Background This study aimed to evaluate the effects of guanfacine on the anterior and posterior segments of the eye. Methods This prospective study included 32 children and adolescents with Attention-deficit/hyperactivity disorder (ADHD). The participants underwent a detailed ophthalmologic evaluation before and 6 months after the beginning of guanfacine treatment. The following data were recorded for each participant: refraction error, intraocular pressure (IOP), anterior chamber depth (ACD), central corneal thickness (CCT), corneal aberrations using corneal topography, retinal nerve fiber layer (RNFL) analysis of seven quadrants (central, nasal, naso-superior, naso-inferior, temporal, temporo-superior, temporo-inferior), central macular thickness (CMT), and choroidal thickness (CT). Assessments were made of these parameters obtained from images using an optical coherence tomography (OCT) instrument. Results A significant increase in total root mean square (RMS) (p = 0.029*), RMS low-order aberration (LOA) (p = 0.014*), Coma 0° (p < 0.001*), and Coma 90° (p = 0.037*) corneal aberrations was observed at the sixth month of guanfacine treatment in comparison with the baseline examination. Other ocular parameters demonstrated no significant change from the baseline examination findings at the sixth month of guanfacine treatment. (p > 0.05, for each). Conclusion Oral guanfacine in the treatment of ADHD had no effect on ocular structures such as the retina, choroid, optic nerve, refraction, or corneal thickness, although it increased corneal aberrations. The results require support through further studies with extended follow-up and a larger patient group.
format Article
id doaj-art-ccb9d19c3a164db2bd46f3932ef83fb5
institution Kabale University
issn 1471-2415
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj-art-ccb9d19c3a164db2bd46f3932ef83fb52025-02-02T12:13:30ZengBMCBMC Ophthalmology1471-24152025-01-012511810.1186/s12886-025-03886-3The effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention-deficit/hyperactivity disorderIşıl Merve Torun0Zeynep Vatansever Pinar1Şeyma İlhan2Department of Ophthalmology, Medical Health Sciences University, Sultan Abdulhamid Han Training and Research HospitalDepartment of Child and Adolescent Psychiatry, Maltepe University, Faculty of MedicineDepartment of Child and Adolescent Psychiatry, Medical Health Sciences University, Kartal Dr Lütfi Kırdar City HospitalAbstract Background This study aimed to evaluate the effects of guanfacine on the anterior and posterior segments of the eye. Methods This prospective study included 32 children and adolescents with Attention-deficit/hyperactivity disorder (ADHD). The participants underwent a detailed ophthalmologic evaluation before and 6 months after the beginning of guanfacine treatment. The following data were recorded for each participant: refraction error, intraocular pressure (IOP), anterior chamber depth (ACD), central corneal thickness (CCT), corneal aberrations using corneal topography, retinal nerve fiber layer (RNFL) analysis of seven quadrants (central, nasal, naso-superior, naso-inferior, temporal, temporo-superior, temporo-inferior), central macular thickness (CMT), and choroidal thickness (CT). Assessments were made of these parameters obtained from images using an optical coherence tomography (OCT) instrument. Results A significant increase in total root mean square (RMS) (p = 0.029*), RMS low-order aberration (LOA) (p = 0.014*), Coma 0° (p < 0.001*), and Coma 90° (p = 0.037*) corneal aberrations was observed at the sixth month of guanfacine treatment in comparison with the baseline examination. Other ocular parameters demonstrated no significant change from the baseline examination findings at the sixth month of guanfacine treatment. (p > 0.05, for each). Conclusion Oral guanfacine in the treatment of ADHD had no effect on ocular structures such as the retina, choroid, optic nerve, refraction, or corneal thickness, although it increased corneal aberrations. The results require support through further studies with extended follow-up and a larger patient group.https://doi.org/10.1186/s12886-025-03886-3Attention-deficit/hyperactivity disorderChoroidCorneal aberrationGuanfacineRetina
spellingShingle Işıl Merve Torun
Zeynep Vatansever Pinar
Şeyma İlhan
The effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention-deficit/hyperactivity disorder
BMC Ophthalmology
Attention-deficit/hyperactivity disorder
Choroid
Corneal aberration
Guanfacine
Retina
title The effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention-deficit/hyperactivity disorder
title_full The effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention-deficit/hyperactivity disorder
title_fullStr The effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention-deficit/hyperactivity disorder
title_full_unstemmed The effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention-deficit/hyperactivity disorder
title_short The effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention-deficit/hyperactivity disorder
title_sort effect of guanfacine treatment on ocular parameters in pediatric and adolescents patients with attention deficit hyperactivity disorder
topic Attention-deficit/hyperactivity disorder
Choroid
Corneal aberration
Guanfacine
Retina
url https://doi.org/10.1186/s12886-025-03886-3
work_keys_str_mv AT isılmervetorun theeffectofguanfacinetreatmentonocularparametersinpediatricandadolescentspatientswithattentiondeficithyperactivitydisorder
AT zeynepvatanseverpinar theeffectofguanfacinetreatmentonocularparametersinpediatricandadolescentspatientswithattentiondeficithyperactivitydisorder
AT seymailhan theeffectofguanfacinetreatmentonocularparametersinpediatricandadolescentspatientswithattentiondeficithyperactivitydisorder
AT isılmervetorun effectofguanfacinetreatmentonocularparametersinpediatricandadolescentspatientswithattentiondeficithyperactivitydisorder
AT zeynepvatanseverpinar effectofguanfacinetreatmentonocularparametersinpediatricandadolescentspatientswithattentiondeficithyperactivitydisorder
AT seymailhan effectofguanfacinetreatmentonocularparametersinpediatricandadolescentspatientswithattentiondeficithyperactivitydisorder